首尔大学、KAIST、延世大学等韩国QS前10名大学的研究室信息。
Professor Jeong-Yoon Lee's research lab focuses on understanding the molecular mechanisms underlying ovarian cancer progression, metastasis, and treatment response. The lab investigates the role of bioactive compounds like genistein in cancer chemoprevention and therapy, particularly in ovarian cancer, while also exploring tumor evolution and immune microenvironment dynamics using advanced genomics and immunophenotyping techniques. A key focus is on identifying predictive biomarkers and therapeutic targets through next-generation sequencing, spatial profiling, and functional immune cell analysis in high-grade serous ovarian cancer.
Professor Jin-Haeng Chung's research lab specializes in translational lung cancer research, focusing on the molecular and immunological characterization of non-small cell lung cancer (NSCLC). The lab investigates biomarkers such as PD-L1 protein and mRNA expression, explores the correlation between histomorphological features and genetic alterations (e.g., ALK rearrangements), and evaluates the reliability and interchangeability of PD-L1 immunohistochemistry assays across different clones and platforms. Their work aims to improve patient stratification for immune checkpoint inhibitor therapy and enhance the accuracy of mediastinal staging using PET imaging and pathological correlation.
Professor Ko Seong-Gyu's research lab focuses on the molecular mechanisms of herbal medicines in cancer prevention and treatment, with a particular emphasis on autophagy, apoptosis, and endoplasmic reticulum stress pathways. The lab investigates natural compounds and herbal extracts—such as kaempferol, Scutellaria baicalensis, and custom formulations like SH003—for their anti-tumor, anti-inflammatory, and neuroprotective effects in preclinical models. Key research directions include targeting signaling pathways like STAT3-IL-6 and IRE1-JNK-CHOP to suppress cancer progression and metastasis, especially in gastric, breast, and prostate cancers.
Professor Jinseong Kim's research lab specializes in the intersection of biomedical engineering, radiation oncology, and artificial intelligence. The lab focuses on developing advanced computational and nanoscale technologies for precision cancer therapy, including AI-driven auto-segmentation for radiotherapy planning, next-generation 2D and 2D+ materials for high-performance transistors, and molecular imaging techniques to detect DNA damage. A central theme is leveraging machine learning and multimodal data—such as medical images, clinical text, and genomic information—to improve cancer diagnosis, treatment planning, and therapeutic outcomes.
Professor Wooram Park's research lab specializes in advanced biomaterials and nanotechnology for biomedical applications, with a focus on developing smart drug delivery systems and nano-therapeutics for cancer and viral diseases. The lab explores innovative solutions in cancer immunotherapy, photodynamic therapy, and nanozyme-based diagnostics and therapeutics, emphasizing targeted delivery and controlled release using stimuli-responsive nanoparticles. A key research direction involves applying principles from nonholonomic systems and stochastic modeling to optimize the navigation and performance of minimally invasive medical devices, such as flexible needles, in complex biological environments. The lab integrates materials science, biomedical engineering, and computational modeling to design next-generation theranostic platforms with enhanced precision and safety.
Professor Chun Soo Lim's research lab focuses on critical care and nephrology, with a strong emphasis on acute kidney injury, electrolyte disorders such as severe hyperkalemia, and the long-term neurological and quality-of-life outcomes following cardiac arrest. The lab investigates the pathophysiology of renal diseases, including IgA nephropathy, and explores the impact of vascular access types on patient outcomes in hemodialysis. A key focus is on identifying predictors of mortality and cognitive dysfunction in critically ill patients, particularly in the post-cardiac arrest population.
Professor Yongho Kim's research lab specializes in the design and engineering of advanced functional materials with applications in environmental health, nanomedicine, and energy technology. The lab focuses on understanding the toxicological impacts of airborne particulate matter from biomass combustion, developing protein-inspired peptides for precise nanostructure assembly, and creating shape- and phase-controlled semiconductor nanocrystals for optoelectronic applications. Additionally, the lab investigates molecular mechanisms of nanoparticle-induced lung injury and designs superhydrophobic materials for chemical threat detection and sensing.
Professor Young-Won Jin's research lab specializes in the discovery and development of bioactive natural products from terrestrial and marine sources, with a focus on identifying compounds that exhibit chemopreventive, antioxidant, and cytotoxic activities. The lab employs bioactivity-guided fractionation and advanced spectroscopic techniques to isolate and characterize novel and known natural compounds, particularly lignans, chalcones, xanthones, and phenolic derivatives, from plants such as licorice, acai, mangosteen, and *Helicteres hirsuta*. Their work emphasizes structure-activity relationships and preclinical evaluation of these compounds against cancer cell lines and oxidative stress models, contributing to the development of potential therapeutic agents.
Professor Hyo-Cheol Kim's research lab specializes in interventional radiology and image-guided cancer therapies, with a primary focus on hepatocellular carcinoma (HCC) and gastrointestinal stromal tumors (GISTs). The lab investigates advanced embolic techniques such as transarterial chemoembolization (TACE) and yttrium-90 radioembolization (TARE), emphasizing optimization of drug delivery systems, imaging biomarkers, and treatment response evaluation. Key research directions include the characterization of extrahepatic collateral vessels, in-vitro and in-vivo pharmacokinetic studies of Lipiodol-based embolic agents, and the development of accurate radiological criteria for tumor diagnosis and treatment planning.
Professor Choon Gon Jang's research lab focuses on neurobehavioral and neuroinflammatory mechanisms underlying environmental toxicants, psychiatric disorders, and natural neuroprotective agents. The lab investigates the behavioral and neurochemical effects of endocrine-disrupting chemicals like bisphenol A, explores the neuropharmacological actions of psychostimulants such as modafinil, and examines the anti-inflammatory properties of herbal extracts—including Lonicera japonica and Eucommia ulmoides—in microglial models. A central theme is the role of neuroinflammation and neurotransmitter systems (e.g., dopamine, glutamate, GABA) in anxiety, depression, and cognitive dysfunction, with translational implications for neuropsychiatric and neurodegenerative disorders.
Professor Jo Yong-gyun's research lab specializes in hepatology and metabolic liver diseases, with a primary focus on nonalcoholic fatty liver disease (NAFLD), its progression to fibrosis, and its links to metabolic syndrome, insulin resistance, and related conditions such as colorectal adenomas and diabetes. The lab conducts large-scale cohort studies to explore the impact of lifestyle factors—like modest alcohol consumption—on liver disease outcomes, particularly in low-risk and young populations. They also investigate the role of hepatic steatosis in early fibrosis progression among patients with chronic hepatitis B and the predictive value of metabolic markers in preclinical diabetes. Their work bridges clinical hepatology with metabolic and epidemiological research.
Professor Kim Bonglee's research lab focuses on identifying and elucidating the molecular mechanisms underlying cancer progression and therapy resistance, with a particular emphasis on endoplasmic reticulum stress, redox homeostasis, and apoptosis regulation. The lab investigates natural compounds—such as thymoquinone, quercetin, and Salvia miltiorrhiza extracts—as potential therapeutic agents that modulate stress response pathways in cancer and other chronic diseases. By targeting key signaling nodes like caspase-9 and the PDGF/PDGFR axis, the lab aims to develop novel, mechanism-based strategies for cancer treatment and disease intervention.
Professor Hyung Kyu Park's research lab specializes in nanomaterials and nanofluidics, focusing on the fundamental transport phenomena of gases and liquids through two-dimensional and carbon-based nanostructures. The lab explores ultrafast water and gas transport in carbon nanotubes, graphene, and molybden disulfide (MoS₂) membranes, emphasizing molecular sieving, energy-efficient separation, and sustainable water purification. They also investigate the synthesis and ion-beam modification of 2D materials, with applications in renewable energy, including solar hydrogen production and nanofluidic devices. Their work bridges nanoscience, materials engineering, and energy sustainability through experimental and theoretical approaches.
Professor Nojun Guo's research lab specializes in machine learning and data analytics, with a strong focus on feature selection, dimensionality reduction, and deep learning applications in real-world problems. The lab develops robust optimization techniques—particularly Lp-norm based methods like L1-norm PCA—for handling noisy and complex datasets, while emphasizing interpretability and computational efficiency. Recent work extends into medical data analysis, such as predicting intradialytic hypotension using recurrent neural networks on time-series clinical data, and image restoration through frequency-domain learning without adversarial training. The lab bridges theoretical advances in information theory and optimization with practical applications in healthcare and image processing.
Professor Hyun Je Kim's research lab specializes in regenerative medicine and biomaterials, focusing on the development of advanced scaffolds and conduits for tissue repair. Key research directions include electrospun silk fibroin-based scaffolds for bone and nerve regeneration, as well as the investigation of natural compounds—such as red ginseng saponins—for their protective effects in liver injury and oxidative stress. The lab also explores neurodegenerative mechanisms, particularly mitochondrial dysfunction in diseases like amyotrophic lateral sclerosis, with an emphasis on gender-related differences. These interdisciplinary efforts integrate materials science, cell biology, and translational medicine to address clinical challenges in orthopedics, neurology, and critical care.
Professor Jung, WooChul's research lab specializes in the design, synthesis, and fundamental understanding of advanced functional oxides for energy conversion and catalysis. The lab focuses on perovskite oxide materials, particularly for solid oxide fuel cell cathodes and electrocatalysts, with an emphasis on surface chemistry, cation segregation, and atomic-scale mechanisms governing oxygen reduction and water splitting. By combining advanced characterization techniques—such as XPS, electron microscopy, and in situ analysis—with theoretical modeling, the lab aims to engineer stable, highly active, and durable nanocatalysts through controlled nanostructuring and interfacial engineering. A key research direction involves the ex-solution of single-atom and nanoscale catalysts on oxide supports to enhance catalytic performance and stability.
Professor Yongsoon Park's research lab focuses on the intersection of clinical nutrition, metabolic health, and cardiovascular disease prevention. Key research directions include the role of bioactive fatty acids—particularly n-3 polyunsaturated fatty acids (EPA and DHA)—in modulating platelet function and inflammation, as well as their impact on lipid metabolism and postprandial triacylglycerol responses. The lab also investigates the effects of dietary bioactive compounds, such as conjugated linoleic acids and sorghum phytochemicals, on metabolic regulation, insulin sensitivity, and nutrient partitioning. Additionally, the lab examines nutritional status and its implications in chronic diseases, particularly protein-energy wasting in end-stage renal disease patients.
Professor Hyunjin Park's research lab specializes in biomedical imaging, radiomics, and biofunctional materials, with a focus on advancing medical diagnostics and therapeutic strategies. The lab develops innovative imaging techniques—such as probabilistic atlases, parametric PET/MRI, and radiomics signatures—to improve the detection and prognosis of cancers, particularly prostate and breast cancer. Additionally, the lab designs biodegradable, bioactive polymers and nanocarriers for enhanced drug delivery and environmental sustainability in agriculture. These interdisciplinary efforts integrate medical imaging, computational modeling, and materials science to address critical challenges in oncology and neurodevelopmental disorders.
Professor Taehee Kim's research lab specializes in advanced materials and biomedical engineering, focusing on the development of functional nanomaterials for energy and healthcare applications. Key research directions include designing smart nanomaterials such as memristors and block copolymer nanostructures for next-generation electronics, and engineering stem cells and non-viral gene delivery systems—particularly using mannosylated chitosan—for targeted immunotherapy and regenerative medicine. The lab also applies computational optimization techniques to solve complex engineering design problems, integrating materials science, nanotechnology, and biomedical engineering to address challenges in disease treatment and device performance.
Professor Tae Hwa Kim's research lab focuses on translational oncology and infectious disease immunology, with a strong emphasis on identifying novel molecular drivers in aggressive cancers such as glioblastoma and nasopharyngeal carcinoma, and evaluating the impact of vaccination and chemotherapy strategies in pediatric and high-risk populations. The lab investigates key signaling pathways—such as those involving PRDX4, integrin α6β4, and S100A4—that drive tumor progression, metastasis, and therapy resistance. Additionally, the lab contributes to public health through epidemiological and clinical studies on antibiotic use and cancer treatment outcomes in Korea. These multidisciplinary efforts aim to bridge basic molecular discoveries with clinical applications to improve patient survival and treatment efficacy.
